Related Experiment Video
Updated: Jun 25, 2026

08:52
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Single-Cell Analysis of Adaptive NK and CMV-Specific T Cell Dynamics after Allogeneic HSCT
Aino Elina Hakkinen1, Jani Huuhtanen1, Sofie Lundgren2
1University of Helsinki, Helsinki, Finland.
Blood Advances
|June 23, 2026
Summary
Cytomegalovirus (CMV) reactivation impacts immune recovery after stem cell transplants. Donor CMV status influences T and NK cell maturation, affecting transplant outcomes and complication management.
Area of Science:
- Immunology
- Transplantation Biology
- Virology
Background:
- Cytomegalovirus (CMV) reactivation is a major complication after allogeneic hematopoietic stem cell transplantation (HSCT), affecting immune reconstitution, morbidity, and mortality.
- Understanding the dynamics of immune recovery, particularly in the context of asymptomatic CMV viremia, is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the impact of asymptomatic CMV reactivation on immune reconstitution following HSCT.
- To characterize the development of T-cell and NK-cell responses in relation to donor cytomegalovirus serostatus.
Main Methods:
- Longitudinal profiling of blood samples from donor-recipient pairs using single-cell RNA and TCR sequencing.
- Analysis of T cells specific to the CMV pp65 epitope and adaptive NK cell maturation.
- Assessment of T-cell chimerism and repertoire expansion.
Main Results:
- Early expansion of monocytes, T cells, and NK cells post-HSCT, with persistent patient CD4+ T cell chimerism.
- Slower maturation of CMV-specific T cells and adaptive NK cells in recipients of grafts from CMV-seronegative donors.
- Rapid adaptive NK cell maturation in CMV-seropositive donor recipients, with higher cytotoxicity observed in CMV-seronegative donor recipients.
- Dominant CD8+ T cell expansions targeting the CMV pp65 epitope, exhibiting terminal maturation.
Conclusions:
- Donor CMV serostatus significantly influences the pace and profile of immune reconstitution after HSCT in the presence of CMV reactivation.
- Findings provide insights into predicting immune recovery timing and inform strategies for managing post-transplant complications related to CMV.
- This study offers a comprehensive single-cell transcriptomic view of adaptive immune recovery post-HSCT with a focus on CMV.

